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Background: Caloric restriction (CR) is considered to increase lifespan and to prevent various age-related diseases
in different nonhuman organisms. Only a limited number of CR studies have been performed on humans, and
results put CR as a beneficial tool to decrease risk factors in several age-related diseases. The question remains at
what age CR should be implemented to be most effective with respect to healthy aging. The aim of our study was
to elucidate the role of age in the transcriptional response to a completely controlled 30 % CR diet on immune
cells, as immune response is affected during aging. Ten healthy young men, aged 20–28, and nine healthy old
men, aged 64–85, were subjected to a 2-week weight maintenance diet, followed by 3 weeks of 30 % CR. Before
and after 30 % CR, the whole genome gene expression in peripheral blood mononuclear cells (PBMCs) was
assessed.
Results: Expression of 554 genes showed a different response between young and old men upon CR. Gene set
enrichment analysis revealed a downregulation of gene sets involved in the immune response in young but not in
old men. At baseline, immune response-related genes were higher expressed in old compared to young men.
Upstream regulator analyses revealed that most potential regulators were controlling the immune response.
Conclusions: Based on the gene expression data, we theorise that a short period of CR is not effective in old men
regarding immune-related pathways while it is effective in young men.
Trial registration: ClinicalTrials.gov, NCT00561145
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Caloric restriction (CR), the restriction of food intake
without malnutrition, increases longevity in Caenorhab-
ditis elegans [31], Saccharomyces cerevisiae [18], and ro-
dents [32]. In addition to longevity, CR minimises the
age-related dysfunction of organs [19] and lowers risks
of several age-related diseases, for example, cancer in
rats and mice [22], and age-related aorta sclerosis in rats
[4]. CR studies in primates led to less conclusive results.* Correspondence: lydia.afman@wur.nl
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(http://creativecommons.org/publicdomain/zeCR did increase longevity in monkeys at the Wisconsin
National Primate Research Centre [6] but did not in-
crease longevity in monkeys at the National Institute of
Aging [20]. Factors such as genetics, husbandry, or diet-
ary composition are perhaps more relevant for longevity
in these primate studies than the number of calories
[20]. Despite contrasting longevity results, both studies
documented beneficial health effects of CR, including
improved immune function and improved glucose
homeostasis [20]. The limited number of studies investi-
gating the effect of a CR diet in humans is, because of
long life expectancy [27], solely directed at beneficial
health effects and not at longevity [15]. For example,
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for coronary heart disease in humans [12]. Also, aging
processes seem to be altered by CR: the gene expression
profiles from skeletal muscles from humans of the CR
Society showed a closer relationship to the gene expres-
sion profiles of young subjects than to those of age-
matched subjects [21]. The preventive or retardative ef-
fect of CR on age-associated changes in gene expression
has also been shown in the muscle, brain, heart, and adi-
pose tissue from other species [23].
Mechanisms underlying beneficial effects of CR re-
main largely unclear. To understand these mechanisms,
genes and molecular pathways involved in the effects of
CR on longevity and healthy aging have been investi-
gated. Overall, the effects of CR are characterised by the
downregulated expression of genes involved in growth
hormone signalling and genes involved in immune re-
sponse [25]. In contrast, aging is characterised by the
upregulated expression of genes involved in immune
response [10]. The opposing effects of CR and aging on
the immune response might be one potential lead for
the beneficial effects of CR on healthy aging. In this re-
gard, immune cells, such as peripheral blood mononuclear
cells (PBMCs), are an interesting target to study in
humans [13, 25]. PBMCs are easily accessible and circulate
in the blood [2], exposing them to metabolites, hormones,
chemokines, or cytokine from tissues such as the liver and
adipose tissue [3], which make them relevant to study. So
far, most human CR studies have been executed in
middle-aged subjects; the question remains at what age
CR should be implemented to be most effective with re-
spect to healthy aging. To approach this question, we
aimed to elucidate the effect of age in the response to CR
by comparing whole genome gene expression response to
3 weeks of 30 % CR in PBMCs from old and young men.
Results
Baseline characteristics for ten young and nine old men
of which high quality microarrays were present are sum-
marised in Table 1. Besides the lower body mass indexTable 1 Baseline characteristics of young (n = 10) and old (n =
9) men of whom microarray analysis on PBMCs was performed.
Data represent mean and (SD) or median and [range]
Young men Old men P value
Age (year) 24 [20, 28] 70 [64, 85] 4.37E−09
Height (m) 1.78 (0.06) 1.77 (0.04) 5.26E−01
Weight (kg) 71.1 (8.52) 76.7 (7.4) 1.28E−01
Body mass index (kg/m2) 22.4 (2.3) 24.6 (2.0) 3.08E−02
Glucose (mmol/L) 4.5 [3.7, 5.1] 5.2 [4.8, 5.5] 5.17E−04
Haemoglobin (g/L) 9.4 (0.4) 9.3 (0.4) 5.69E−01
Haematocrit (%) 45 (2) 44 (2) 5.46E−1(BMI, P = 0.04) and lower fasting glucose level (P < 0.001)
in old compared to young men, no differences were
observed.
Three weeks of CR resulted in a decrease in body
weight and BMI in both groups (Table 2). Age had no
effect on weight (P = 0.18) or BMI change (P = 0.18).
Effect on gene expression: old versus young
At baseline, before 30 % CR, 696 genes were significantly
differently expressed between old and young men
(Fig. 1a). To identify the effect of age on CR-induced
gene expression changes, responses to CR were com-
pared between old and young men (Fig. 1b). A total of
554 genes showed a significantly different expression re-
sponse between old and young men.
Effect of CR on gene expression: pathway analysis
Gene Set Enrichment Analysis (GSEA) was used to iden-
tify pathways in which gene expression was differentially
regulated by age, at baseline, or in response to CR. Be-
fore the start of the 30 % CR diet, the expression of
genes involved in immune response was higher in old
compared to young men and the expression of genes in-
volved in RNA processing was lower in old compared to
young men (Table 3). Upon 3 weeks of 30 % CR, the ex-
pression of genes involved in immune response and glu-
cose metabolism was downregulated in young men only,
whereas the expression of genes involved in olfactory
signalling was downregulated in old men only.
Upstream regulator analysis
Ingenuity Pathway Analysis (IPA) Upstream Regulator
Analysis is a tool to find transcription regulators that
may explain the observed gene expression. To identify
these upstream regulators of genes that had a different
expression before CR between old and young, or had
a changed expression upon CR, we performed IPA
Upstream Regulator Analysis. The regulators that
were predicted to be affected at baseline and upon
CR are listed in Additional file 1: Table S1. This list
shows immune-related upstream regulators, interferon
lambda 1 (INFL1), interferon alpha 2 (IFNA2), and
interferon gamma (IFNG), that were predicted to be
significantly higher in old compared to young before
intervention. IFNA2 and IFNG were inhibited upon
CR in young men, but not in old men. To identify
correlation between the genes predicted to be regu-
lated, we selected all significantly changed genes tar-
geted by the predicted transcriptional regulators upon
CR and created correlation heat maps of the signifi-
cant changes in expression of these genes for young
men (Fig. 2 (A1)) and old men (Fig. 2 (A2)). For
young men, 57 unique genes were affected by the six
identified transcriptional regulators, i.e. IFNA2, IFNG,
Table 2 Body weight and body mass index of young and old men before and upon 3 weeks of 30 % CR and significance (P value).
Data represent mean with (SD)
Before CR Upon CR P value
Weight (kg) Young (n = 10) 71.1 (8.5) 68.7 (8.6) 2.87E−05
Old (n = 9) 76.7 (7.4) 74.9 (7.4) 6.53E−05
Body mass index (kg/m2) Young (n = 10) 22.4 (2.3) 21.6 (2.3) 3.64E−05
Old 9 (n = 9) 24.6 (2.0) 24.0 (2.0) 4.21E−05
Van Bussel et al. Genes & Nutrition  (2016) 11:13 Page 3 of 9eukaryotic translation initiation factor 2-alpha kinase 2
(EIF2AK2), mitogen-activated protein kinase 1 (MAPK1),
glyceraldehyde-2-phosphate dehydrogenase (GAPDH),
and transglutaminase 2 (TGM2) (Additional file 1:
Table S1). These genes showed a distinct correlation
in young men (Fig 2 (A1)) which was less strong or
absent in old men (Fig 2 (A2)). Contrary for old men,
many genes regulated by the upstream regulators
were overlapping: 15 potential upstream regulatorsFig. 1 Stepwise selection of genes in microarray analysis of old
versus young men upon 3 weeks of 30 % CR: 12,783 genes were
selected for signal intensity (≥5 in >5 arrays), a for a difference in
expression between old and young (P < 0.05) men at baseline (left
track) and upon CR (right track), and b a change in expression of
genes for young (left track) and old (right track) in response to CR.
The last box depicts the number of genes that has a different
response to CR in old versus young men(Additional file 1: Table S1) were predicted to affect
17 unique genes, and no specific correlation pattern
for old could be identified (Fig. 2 (B)).
Younger transcriptional profile upon CR
To identify if old men were able to obtain, at least for a
subset of genes, a younger gene expression profile upon
CR, the following approach was used: selection of genes
with a different expression between old and young be-
fore CR resulting in 696 genes (Fig. 3); 96 of these genes
also showed a significant different response upon CR be-
tween old and young men (Fig. 3); 55 of these genes had
a changed expression in old men only. Figure 4 shows a
heat map of the gene expression per subject and illus-
trates the different expressed genes at baseline and the
change towards a young profile in old men, as is shown
by the third part of the heat map where no significant
expression differences between old and young upon CR
were present.
Discussion
We aimed to investigate the potential relevance of age at
which CR should be implemented to be most effective
on gene expression changes of pathways important for
healthy aging. To achieve this, we compared the gene
expression changes in PBMCs of old men with the gene
expression changes in PBMCs of young men upon
3 weeks of 30 % CR.
Three weeks of CR resulted in a downregulated
expression of genes involved in immune response and
glucose metabolism in young but not in old men. EffectsTable 3 Pathways changed in PBMC gene expression profiles of
young and old men before and upon 3 weeks of 30 % CR
Pathway Baseline (old vs young) Young men Old men
RNA processing ↓ ↑ ↑
Cell cycle – ↑/↓a ↑/–a
Oxidative stress – ↓ ↓
Immune response ↑ ↓ –
Glucose metabolism – ↓ –
Olfactory signalling – – ↓
↓ downregulated, ↑ upregulated, – no change
aPart of gene sets classified under these pathways were upregulated, whereas
others where downregulated
Fig. 2 Correlation heat maps of CR-induced significant changes in gene expression of (A) genes regulated by upstream regulators in young,
depicted for the response in young (A1) and old (A2), and of (B) genes regulated by upstream regulators in old, depicted for the response in
young (B1) and old (B2). Scale: green = correlation score of −1, pink = correlation score of 1
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been shown before; 8 weeks of CR in middle-aged obese
men downregulated the expression of genes involved in
immune response in PBMCs [7]. The response of these
middle-aged obese men is similar to the response of
young men in our study. One reason why we do not see
the response in old men might be due to ‘immunosenes-
cence’ [24], known to take place in elderly individuals
above 65 years of age. Immunosenescence means the
loss of immune functions and is characterised by an in-
crease in the expression of inflammation- and immune
response-related genes [10]. Although the overlap be-
tween the genes in this paper and in the current study is
minimal, we also observed an increase in gene expres-
sion and a predicted activation of transcriptional regula-
tors involved in immune pathways, i.e. IFNA2 and
IFNG, in old men at baseline when compared to young.
Upon CR, a decreased activation of IFNA2 and IFNG
was only observed in young men. MAPK1 was activatedupon CR. MAPK1 represses the expression of IFNG-
induced genes via DNA-binding [16]. An increase in
MAPK1 might have affected the decrease in IFNG-
induced genes. The potential immunosenescence present
at baseline may be the reason why we do not see a re-
sponse on immune-related pathways upon CR in the old
men. This is further illustrated by the correlation heat
maps of immune-related genes in which high correla-
tions are observed between gene expression responses in
young men and far less pronounced effects are observed
in old men. Old men seem to have lost the ability to
change gene expression in immune response upon CR.
This inability to change expression might be due to a
potential advanced aging-related state of epigenetics,
keeping the DNA structure in a more rigid structure
and making it less likely to change gene expression.
Either 3 weeks of 30 % CR is not sufficient to reduce the
higher gene expression of immune-related genes in old
men or the age-related potential epigenetic changes are
Fig. 3 Stepwise selection of genes in microarray analysis to identify genes in which expression changed from an old profile to a young profile upon
3 weeks of 30 % CR. For signal intensity, 12,783 genes were selected (≥5 in >5 arrays); from these, 96 genes were selected that were differently expressed
between old and young men before CR (P< 0.05); the last part depicts number of genes that show a different response to CR in old versus young men.
Finally, 23 genes with a significant change in expression within young (left track) men and 55 genes within old (right track) men are shown
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at an earlier age. Three weeks of CR also resulted in a
downregulated expression of genes involved in glucose me-
tabolism in young men only. We did not find a difference
in the expression of genes involved in glucose metabolism
at baseline between old and young men, even though aging
is known to have a diminishing effect on adequate glucose
metabolism [9]. Aging might, however, have played a
role in the nonresponsive effect of our short-term CR
on glucose metabolism-related pathways in old men.
The decreased expression of genes related to olfactory
signalling pathways in old men has not been described
in the literature. However, other studies in fruit flies
have been done in which the absence of odorants from
nutrients affected the expression of odorant-binding
proteins [26]. In addition, it has been described before in
yeast that CR has an increasing effect on the expression
of genes involved in RNA processing [5] as seen in our
study for both young and old men.
Although old men did not respond with the same
changes on immune response and glucose metabolism,
many genes did show a change in expression upon CR.
We identified a group of genes that changed from an ‘old’
expression level towards a ‘young’ expression level uponCR. This was in line with the finding that the expression
of genes from the skeletal muscle tissue of middle-aged
subjects of the Caloric Restriction Society matched closer
to gene expression profiles of younger subjects than to
gene expression profiles of age-matched controls [21]. We
could, however, not find any clear signalling route, path-
way, or network for these genes.
It should be mentioned that both baseline differences
and differences in gene expression changes between young
and old can be due to different subpopulations of immune
cells in the PBMCs between the groups. During aging, in-
volution of the thymus, responsible for production of
naïve T cells, leads to a shift in the T cell population [14].
Unfortunately, we did not have the opportunity to deter-
mine PBMC subpopulations. Furthermore, a period of
3 weeks of CR is short and might not have been long
enough to induce changes in the gene expression of old
men. A strength of our study design is the completely
controlled dietary run-in period of 2 weeks and the com-
pletely controlled dietary 30 % CR intervention of 3 weeks
which excludes a potential effect of habitual diet differ-
ences between the young and old men on gene expression
differences at baseline and on gene expression response
upon CR.
Fig. 4 Heat map of genes of which expression changed from an old profile to a young profile upon CR. (a) baseline expression level, (b)
response to CR, and (c) expression levels after CR for young and old men. Each column represents one person; each row represents one gene.
Depicted are for (a) the signal log ratio calculated as gene expression values at baseline compared to the average of the whole group, for (b) the
signal log ratios calculated as gene expression values upon CR compared to gene expression values at baseline, and for (c) the signal log ratios
as gene expression values after CR compared to the average of the whole group.
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In our study, the expression of genes involved in im-
mune response pathways was higher in old compared to
young men at baseline. Three-week 30 % CR did not
affect this higher immune-related gene expression in old
men whereas it did reduce immune-related gene expres-
sion in young men. Due to our small sample size, we
cannot draw solid conclusions about the relevance of
age on the effect of CR on gene expression changes ofpathways important for healthy aging. We hypothesise
based on immune-related gene expression changes in
men that for a short period of 30 % CR a young onset
has more potential benefit than an old onset.
Methods
Study population and eligibility criteria
Our study population was a subgroup of participants who
participated in a previously reported controlled-feeding
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publishing advertisements in local newspapers and by
sending out general e-mails to an e-mail list of persons
who had indicated their interest in participating in
studies of our university, at Wageningen University
(The Netherlands), in October 2007 till January 2008,
and followed up until the 15th of March 2008. Partic-
ipants were excluded based on the following criteria:
body mass index (BMI, kg/m2) less than 20 or higher
than 30, adherence to a weight-reduction or medically
prescribed diet, dementia (Mini-Mental State Examin-
ation score <21), diabetes, anaemia, gastrointestinal
disorders, use of drugs known to interfere with en-
ergy balance, or a history of medical or surgical
events known to affect the study outcome. Partici-
pants were divided based on their age into young
(20–40 years) and old (65–85 years) men. Based on
these criteria, 15 young and 17 old men were in-
cluded in the original study at Wageningen University
(The Netherlands) [34]. Microarray analyses were per-
formed on high-quality PBMC RNA of ten young
men, age range 20–28 years, and nine old men, age
range 64–85 years (Fig. 5).
Each of the participants was informed about the
design and purpose of the study, and each of the
participants provided written informed consent. The
Medical Ethical Committee of Wageningen University
(The Netherlands) approved the study. This clinical study
was registered with ClinicalTrials.gov as NCT00561145.
Study design
The original study consisted of three subsequent phases as
described previously [34] and was all carried out at the
Division of Human Nutrition of Wageningen University
(The Netherlands). Only samples collected after phases 1
and 2 are the subject of the current paper. Phase 1 (days
1–14): controlled dietary intervention in which each ofFig. 5 Flow diagram of subject inclusionthe participants had to remain weight stable. Each of the
participants was provided with a diet containing approxi-
mately 90 % of their estimated total daily energy require-
ment. The remaining 10 % was chosen from a list of
choice items. In phase 2 (days 15–35): each of the partici-
pants was provided with a diet containing 70 % of the
energy consumed during the last 3 days of phase 1. Com-
position of the diets was determined as described in [34].
Blood samples were taken at the end of phase 1, before
CR, and at the end of phase 2, after CR.
PBMC RNA isolation and microarray processing
PBMCs were isolated from whole blood using BD
Vacutainer® Cell Preparation Tubes™ according to the
manufacturer’s instructions. Total RNA was isolated
from PBMC samples using TRIzol reagent (Invitrogen,
Breda, The Netherlands) and purified using Qiagen
RNeasy Micro Kit (Qiagen, Venlo, The Netherlands).
RNA integrity was checked with Agilent 2100 Bioanalyzer
(Agilent Technologies, Amstelveen, The Netherlands).
Total RNA (500 ng/sample) was labelled using a one-cycle
cDNA labelling kit (MessageAmpTM II-Biotin Enhanced
Kit; Ambion Inc., Nieuwerkerk aan de IJssel, The
Netherlands) and hybridised to human whole genome
GeneChip arrays encoding 17,054 genes, designed by the
European Nutrigenomics Organization and manufactured
by Affymetrix (Santa Clara, CA). Sample labelling,
hybridization to chips, and image scanning were per-
formed according to the manufacturer’s instructions.
Microarray data analysis
Quality control was performed and fulfilled the criteria
for array hybridisation suggested by the Tumor Analysis
Best Practices Working Group [30].
Microarrays were analysed using reorganised oligo-
nucleotide probes as described by Dai et al. [8]. All indi-
vidual probes for a gene were combined, allowing the
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basis of latest genome and transcriptome information,
rather than on the basis of Affymetrix probe set annota-
tion. Expression values were calculated with the Robust
Multi-array Average (RMA) method and quantile nor-
malised [1, 17]. Only probe sets with normalised signals
>5 on ≥5 arrays were defined as expressed and selected
for analysis. This normalisation level was chosen because
of a low microarray intensity level, due to the use of ex-
pired microarrays. It has, however, been shown that
microarray data generated by microarrays more than
4 years past the manufacturer’s expiration date had
lower signal intensities but were highly specific and con-
sistent with those from unexpired microarrays [33]. We
used microarrays within 2 years of the expiry date.
Individual genes were defined as changed when com-
parison of the average normalised signal intensities
showed a P value <0.05 in a two-tailed paired t test with
Bayesian correction (Limma) [29]. Filtered data were ana-
lysed with Gene Set Enrichment Analysis (GSEA; GSEA/
MSigDB website v3.87 released April 4, 2013). Signifi-
cantly regulated gene sets were defined with a false discov-
ery rate of <0.25. Gene sets were visualised and clustered
using Cytoscape [28], which enabled the identification of
clusters of gene sets. Ingenuity Pathway Analysis version
8.5 (Ingenuity Systems, Redwood City, CA) was also used
for pathway analysis and upstream regulator analysis, but
because of similar results, only GSEA results are dis-
played. Ingenuity Pathway Analysis has been performed
based on findings from human experiments.
For upstream regulator analysis at baseline, genes with a
significant different expression at baseline were included (P
< 0.05). For young, genes with a significant different response
upon CR in young were included (P < 0.05), and for old,
genes with a significant different response upon CR in old
were included (P < 0.05). For correlation heat maps, target
genes of the upstream regulators were included if they also
had a significantly different response between old and young
(P < 0.05) upon CR. Array data have been submitted to Gene
Expression Omnibus under accession number GSE63117.
Statistical analysis of clinical measurements
The statistical package SPSS (version 15.0; SPSS Inc,
Chicago, IL) was used for analysis of the following data:
expression changes within age groups were determined
by paired t tests, and differential changes between age
groups were determined by unpaired t tests.
Availability of supporting data
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geo/. Additional data can be found in supplemental files.
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